$1.42
▼ -0.4% Today
as of Sep 4, 16:50 ET
Last 30 days
Recent Press Releases & News
INOVIO to Participate in Upcoming Investor Conferences
--Jefferies Upgrades Inovio Pharmaceuticals to Buy From Hold, Adjusts PT to $3 From $1.80
Inovio Pharmaceuticals Inc (INO) (Q2 2026) Earnings Call Highlights: INO-3107 on Track for ...
Overview
52-week range
$0.56
$2.98
36% of range
Avg surprise (last 3)
+13.6%
Avg reaction (last 2)
-3.0%
0% positive
Latest IV / EM
1896%
EM ±79.2% · $1 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.07 | — | — | — | — | financials |
| Wed May 13, 2026 | Mar/2026 | $-0.28 | $-0.30 | +6.7% | +45.1% | -5.0% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.87 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.61 | $-0.63 | +3.2% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.51 | $-0.74 | +31.1% | — | -1.0% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.89 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-1.19 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.31 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-1.52 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-1.61 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-1.89 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | — | $0 | $0 | $65,343 | — | $0 |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-19M | $-22M | — | $-21M | $-23M | $-25M | — | $-27M |
| Net income | $-6M | $-20M | — | $-45M | $-24M | $-20M | — | $-25M |
| EPS (diluted) | $-0.07 | $-0.28 | — | $-0.87 | $-0.61 | $-0.51 | — | $-0.89 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $32M | $26M | $44M | $37M | $24M | $40M | $66M | $22M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $40M | $39M | $61M | $55M | $53M | $72M | $98M | $91M |
| Total assets | $49M | $50M | $74M | $69M | $68M | $87M | $113M | $107M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $45M | $44M | $50M | $77M | $40M | $36M | $45M | $34M |
| Total equity | $4M | $6M | $24M | $-8M | $29M | $51M | $69M | $74M |